Annovis Bio (ANVS) analyst forecast and price target
Analyst forecast
Consensus of 3 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Roth Capital | Maintained | Buy | $7.00 from $8.00 | Aug 28, 2026 |
| Canaccord Genuity | Maintained | Buy | $17.00 | Aug 18, 2026 |
| Roth Capital | Initiated Coverage | Buy | $8.00 | Jul 8, 2026 |
| Canaccord Genuity | Maintained | Buy | $17.00 | Apr 14, 2026 |
| Canaccord Genuity | Maintained | Buy | $17.00 | Sep 30, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 from $12.00 | Sep 3, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 from $30.00 | Jun 9, 2025 |
| Canaccord Genuity | Maintained | Buy | $17.00 from $26.00 | May 15, 2025 |
| D. Boral Capital | Downgraded | Buy → Hold | — | Feb 10, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Nov 11, 2024 |
| D. Boral Capital | Maintained | Buy | $21.00 | Nov 11, 2024 |
| Maxim Group | Upgraded | Hold → Buy | $25.00 | Oct 25, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Oct 16, 2024 |
| EF Hutton | Maintained | Buy | $21.00 | Oct 15, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Oct 1, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Aug 15, 2024 |
| EF Hutton | Maintained | Buy | $21.00 | Aug 15, 2024 |
| EF Hutton | Initiated Coverage | Buy | $21.00 | Aug 13, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Jul 17, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 from $23.00 | Jul 11, 2024 |
Frequently asked questions
Is ANVS a buy, sell, or hold?
Analysts covering Annovis Bio currently average a Buy rating: 3 buy, 0 hold and 0 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on ANVS?
On Aug 28, 2026, Roth Capital maintained Annovis Bio at Buy with a price target of $7.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.